Dual Lineage Tracing Identifies Cellular Mechanisms Underlying Radiation-Associated Changes in Atherosclerotic Lesion Composition
Rebecca A. Deaton, Tajbir Raihan, Victoria M. Milosek, Fatema Allaham, Alexandra L. Krinsky, Laura S. Shankman, Alexander M. Como, Gabriel F. Alencar, Anita Salamon, Nazanin Moradinasab, Subhashis Banerjee, Gary K. OwensBACKGROUND:
Phenotypic plasticity of smooth muscle cells (SMCs) and endothelial cells (ECs) contributes to atherosclerotic plaque composition and stability, yet how shifts in one population influence the contribution and function of the other under conditions of vascular stress, such as irradiation, is poorly understood. A major limitation has been the inability to simultaneously fate-map both cell types within the same lesion, with most studies mapping one lineage while inferring the other using unreliable dynamically changing marker genes, risking false-positive and false-negative assignment.
METHODS:
We generated dual lineage tracing
RESULTS:
Dual lineage tracing simultaneously labeled SMC- and EC-derived cells in healthy and atherosclerotic vessels. Irradiation induced divergent responses: SMC-derived cells failed to invest in lesions and upregulated stress-activated inflammatory genes, whereas EC-derived cells expanded and upregulated SMC-associated genes. However, EC-derived cells within lesions failed to induce extracellular matrix genes, and lesions from irradiated mice exhibited reduced collagen content and fewer ACTA2 (smooth muscle actin alpha 2) + cells within the fibrous cap, consistent with reduced plaque stability.
CONCLUSIONS:
Dual lineage tracing of SMCs and ECs demonstrated that irradiation-induced loss of lesional SMC and expansion of EC-derived ACTA2 + cells are not artifacts of false lineage assignment. By resolving SMC and EC fate within the same lesion, we identify irradiation-induced cell dynamics including inflammatory reprogramming of SMCs, EC phenotypic modulation, impaired extracellular matrix organization, and reduced ACTA2 + fibrous cap cellularity that may contribute to radiotherapy-associated increased atherosclerotic cardiovascular disease risk.